VYNE Therapeutics
VYNE
VYNE
38 hedge funds and large institutions have $11.5M invested in VYNE Therapeutics in 2025 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
51% less capital invested
Capital invested by funds: $23.4M → $11.5M (-$12M)
Holders
38
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.01M | |
| 2 | +$520K | |
| 3 | +$406K | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$300K |
| 5 |
EAM
Exome Asset Management
New York
|
+$173K |
Top Sellers
| 1 | -$4.67M | |
| 2 | -$316K | |
| 3 | -$206K | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$145K |
| 5 |
Jane Street
New York
|
-$68K |
